期刊文献+

免疫组织化学在乳腺普通型与不典型导管增生诊断中的意义 被引量:1

Value of immunohistochemistry in diagnosis of usual and atypical ductal hyperplasia of the breast
暂未订购
导出
摘要 目的探讨细胞角蛋白(CK)5、CK5/6、CK34βE12、雌激素受体(ER)及孕激素受体(PR)在乳腺普通型导管增生(UDH)与不典型导管增生(ADH)中的表达及应用意义。方法选取115例UDH和42例ADH,采用免疫组织化学EnVision二步法检测CK5、CK5/6、CK34βE12、ER和PR的表达。结果 CK5、CK5/6、CK34βE12阳性率在UDH分别为98.3%、94.8%、97.4%,在ADH分别为40.5%、54.8%、52.4%,在UDH的表达高于ADH(χ~2值分别为72.14、36.80、49.85,均P<0.01)。ER与PR在UDH主要呈不均一性阳性(87.8%、84.4%),在ADH主要呈均一性强阳性或阴性(54.76%、52.38%),两者差异有统计学意义(χ~2值分别为30.98、21.86,均P<0.01)。结论 CK5、CK5/6、CK34βE12、ER及PR可作为UDH和ADH诊断与鉴别诊断的客观辅助指标,联合检测对准确诊断UDH与ADH有重要意义。 Objective To investigate the expressions of CK5,CK5/6,CK34βE12,ER and PR in usual ductal hyperplasia(UDH)and atypical ductal hyperplasia(ADH)of the breast and their significance.Methods Immunohistochemical staining(EnVision method)was performed to detect the expression of CK5,CK5/6,CK34βE12,ER and PR in 115 cases of UDH and 42 cases of ADH.Results The positive rate of CK5,CK5/6 and CK34βE12 in UDH was 98.3%,94.8%and 97.4%,respectively.But in ADH was 40.5%,54.8%and 52.4%,respectively.The expression of CK5,CK5/6 and CK34βE12 were higher in UDH than in ADH(χ2 value was 72.14,36.80 and 49.85,respectively,all P〈0.01).ER and PR presented variable positive expression in UDH but homogeneously strong positive or negative expression in ADH(χ2 value was 30.98 and 21.86,respectively,both P〈0.01).Conclusion CK5,CK5/6,CK34βE12,ER and PR can be considered as useful indexes in differential diagnosis of UDH and ADH.
作者 赵可 钱建忠 徐洪明 Zhao Ke;Qian Jianzhong;Xu Hongming(Department of Pathology,Affiliated Jiangyin Hospital,Medical College of Southeast University,Jiangyin 214400,China)
出处 《山西医药杂志》 CAS 2018年第12期1389-1391,共3页 Shanxi Medical Journal
关键词 免疫组织化学 乳腺疾病 增生 诊断 Immunohistochemistry Breast diseases Hyperplasia Diagnosis
  • 相关文献

参考文献3

二级参考文献36

  • 1张景丽,张红英,魏兵,郎志强,步宏.细胞角蛋白在乳腺导管内增生性病变鉴别诊断中的应用[J].中华病理学杂志,2004,33(4):316-319. 被引量:9
  • 2于志勇,于金明,吴泰璜,卓培英,王圣芳,李美,张霞,吕宝玉,刘雁冰.乳腺癌分子生物学特性检测的临床意义[J].中华肿瘤杂志,2005,27(7):420-422. 被引量:14
  • 3郎志强,魏兵,步宏,张红英,李新军,陈卉娇.基底型细胞角蛋白在乳腺导管内增生性病变诊断中的应用[J].临床与实验病理学杂志,2006,22(1):19-23. 被引量:16
  • 4Livasy C A, Perou C M, Karaca G, et al. Identification of a basal- like subtype of breast ductal carcinoma in situ [ J ]. Hum Pathol, 2007,38 (2) : 197 - 204.
  • 5Bryan B B, Schnitt S J, Collins L C, et al. Ductal carcinoma in situ with basal-like phenotype : a possible precursor to invasive bas- al-like breast cancer [ J ]. Mod pathol, 2006,19 ( 5 ) :617 - 21.
  • 6Dabbs D J, Chivukula M, Carter G, et al. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile [ J]. Mod Pathol, 2006,19 ( 11 ) : 1506 - 11.
  • 7Tamimi R M, Baer H J, Marotti J, et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer [ J 1. Breast Cancer Res, 2008,10 (4) : R67.
  • 8Moriya T, Kozuka Y, Kanomata N, et al. The role of immunohis- tochemistry in the differential diagnosis of breast lesions [ J ]. Pa- thology, 2009,41 ( 1 ) :68 - 76.
  • 9Hicks D G. Immunohistoehemistry in the diagnostic evaluation of breast lesions[ J. Appl Immunohistochem Mol Morphol, 2011, 19 (6) :501 -5.
  • 10Bodian CA,Perzin KH,Lattes R. Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications[J].Cancer,1993,(12):3908-3913.

共引文献13

同被引文献10

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部